Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to -$46.2 million.

  • Surgery Partners' Cash from Investing Activities rose 685.48% to -$46.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$232.2 million, marking a year-over-year increase of 4660.84%. This contributed to the annual value of -$488.5 million for FY2024, which is 11653.37% down from last year.
  • As of Q3 2025, Surgery Partners' Cash from Investing Activities stood at -$46.2 million, which was up 685.48% from $2.1 million recorded in Q2 2025.
  • Surgery Partners' Cash from Investing Activities' 5-year high stood at $2.1 million during Q2 2025, with a 5-year trough of -$244.1 million in Q2 2024.
  • In the last 5 years, Surgery Partners' Cash from Investing Activities had a median value of -$70.7 million in 2023 and averaged -$77.6 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 44470.99% in 2021, then soared by 10086.03% in 2025.
  • Surgery Partners' Cash from Investing Activities (Quarter) stood at -$190.0 million in 2021, then skyrocketed by 62.0% to -$72.2 million in 2022, then grew by 19.53% to -$58.1 million in 2023, then tumbled by 92.25% to -$111.7 million in 2024, then skyrocketed by 58.64% to -$46.2 million in 2025.
  • Its Cash from Investing Activities was -$46.2 million in Q3 2025, compared to $2.1 million in Q2 2025 and -$76.4 million in Q1 2025.